Skip to Content

← See all CLENZIDERM PORE THERAPY ACNE TREATMENT brands

CLENZIDERM PORE THERAPY ACNE TREATMENT

Dosage form: solution
Ingredients: SALICYLIC ACID 20mg in 1mL
Labeler: Valeant Pharmaceuticals North America LLC
NDC Code: 0187-6102

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

OBAGI® MEDICAL
CLENZIderm M.D.™
Pore Therapy
Refreshing CLENZIderm M.D.™ Pore Therapy unclogs and refines pores and clears away dead skin cells with 2% salicylic acid.

DRUG FACTS

Active Ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Uses
For the treatment of acne.
Dries up acne pimples.
Helps prevent new acne pimples.

Warnings

For external use only.

When using this product
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Stop use and ask a doctor if
irritation becomes severe.

Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Directions
Cleanse the skin thoroughly before applying this product.
Shake product well before use.
Cover the entire affected area with a thin layer one to three times daily.
Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other Information
Store away from heat and direct sunlight.
Store at controlled room temperature: 15°C-25°C (59°F-77°F).

Inactive Ingredients

benzalkonium chloride, benzyl alcohol, ethoxydiglycol, ext. D&C Violet 2, fragrance, glycerin, menthol, menthoxypropanediol, menthyl lactate, SD alcohol 40-B (alcohol denat.), water

Questions or comments?

1.800.636.7546

Monday-Friday 9a.m.-4p.m. Pacific Time

Distributed by Obagi Medical Products, a division of
Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA
®/TM are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates.
© OMP, Inc. www.obagi.com 9426302

PRINCIPAL DISPLAY PANEL - 148 mL Bottle Label

OBAGI®

MEDICAL

CLENZIderm M.D.™

Pore Therapy

Salicylic Acid 2%
Acne Treatment

5 fl. oz. (148 mL)

CLENZIDERM PORE THERAPY  ACNE TREATMENT
salicylic acid solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0187-6102
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ALCOHOL 
DIETHYLENE GLYCOL MONOETHYL ETHER 
BENZYL ALCOHOL 
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL 
GLYCERIN 
BENZALKONIUM CHLORIDE 
MENTHOL, UNSPECIFIED FORM 
MENTHYL LACTATE, (-)- 
EXT. D&C VIOLET NO. 2 
WATER 
Product Characteristics
ColorPURPLEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:0187-6102-04148 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D03/02/2015
Labeler - Valeant Pharmaceuticals North America LLC (042230623)
Establishment
NameAddressID/FEIOperations
Ei INC.105803274MANUFACTURE(0187-6102), LABEL(0187-6102), PACK(0187-6102), ANALYSIS(0187-6102)

 
Valeant Pharmaceuticals North America LLC

← See all CLENZIDERM PORE THERAPY ACNE TREATMENT brands

Medically reviewed on Nov 30, 2017

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide